This research indicated that ω-3 PUFAs could alleviate CLP-induced inflammatory response and multi-organ damage in rats with sepsis by regulating the AMPK/mTOR signaling pathway; thus, may be used as a potential therapeutic agent for the treatment of sepsis. This evidence concerns the gene MTOR and Sepsis.